These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33951331)

  • 21. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies.
    Mejdoub S; Feki S; Dammak M; Farhat N; Hdiji O; Boukthir S; Hachicha H; Mhiri C; Masmoudi H
    Rev Neurol (Paris); 2020 May; 176(4):261-267. PubMed ID: 31668529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiological characteristics of neuromyelitis optica spectrum disorder in Kuwait.
    Ismail II; Ahmed SF; Al-Hashel JY; Abdelnabi EA; Alroughani R
    Clin Neurol Neurosurg; 2020 Sep; 196():106047. PubMed ID: 32604036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.
    Nishimura H; Enokida H; Sakamoto T; Takahashi T; Hayami H; Nakagawa M
    J Artif Organs; 2018 Sep; 21(3):378-382. PubMed ID: 29675599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resolution of inflammation in neuromyelitis optica spectrum disorders.
    Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
    Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
    Akaishi T; Takahashi T; Fujihara K; Misu T; Fujimori J; Takai Y; Nishiyama S; Abe M; Ishii T; Aoki M; Nakashima I
    J Neurol; 2021 May; 268(5):1938-1944. PubMed ID: 33416998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review.
    Shahmohammadi S; Doosti R; Shahmohammadi A; Mohammadianinejad SE; Sahraian MA; Azimi AR; Harirchian MH; Asgari N; Naser Moghadasi A
    Mult Scler Relat Disord; 2019 Jan; 27():350-363. PubMed ID: 30476871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
    Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
    Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AQP4-IgG positive paraneoplastic NMOSD: A case report and review.
    Ding M; Lang Y; Cui L
    Brain Behav; 2021 Oct; 11(10):e2282. PubMed ID: 34520629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated with Atypical Thymic Carcinoid: A Case Report.
    Mitsui S; Tanaka Y; Kimura K; Jimbo N; Chihara N; Maniwa Y
    Ann Thorac Cardiovasc Surg; 2022 Oct; 28(5):362-365. PubMed ID: 33907053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
    Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
    J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syringomyelia-like syndrome in neuromyelitis optica spectrum disorder complicated with Sjogren's syndrome: a case report.
    Li X; Lu Z; Wang Y
    BMC Neurol; 2018 Oct; 18(1):168. PubMed ID: 30301458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aquaporin-4-antibody-positive Neuromyelitis Optica Spectrum Disorder in a Patient with Charcot-Marie-Tooth Disease Type 1A.
    Hamada Y; Takahashi K; Kanbayashi T; Hatanaka Y; Kobayashi S; Sonoo M
    Intern Med; 2021 May; 60(10):1611-1614. PubMed ID: 33361678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differential diagnosis of neuromyelitis optica spectrum disorders].
    Tanaka K; Tanaka M
    Brain Nerve; 2010 Sep; 62(9):953-60. PubMed ID: 20844306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pontine hemorrhage accompanied by neuromyelitis optica spectrum disorder.
    Kamo H; Ueno Y; Sugiyama M; Miyamoto N; Yamashiro K; Tanaka R; Yokoyama K; Hattori N
    J Neuroimmunol; 2019 May; 330():19-22. PubMed ID: 30769213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromyelitis optica spectrum disorder associated with dengue virus infection.
    Lana-Peixoto MA; Pedrosa D; Talim N; Amaral JMSS; Horta A; Kleinpaul R
    J Neuroimmunol; 2018 May; 318():53-55. PubMed ID: 29475624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of aquaporin 4 antibody in the injury of retinal microstructure in neuromyelitis optica spectrum disorders].
    Wang ZW; Wang QQ; Diao DW; Guo QF; Qi XK
    Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):435-439. PubMed ID: 29925129
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of Neuromyelitis Optica Spectrum Disorders.
    Chan KH; Lee CY
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
    Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
    Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.